Maria Sygidus, MSc

PhD Student

ABOUT ME:

DEAFinitely into brains, not sounds

I graduated from the Medical University of Silesia, where I had the opportunity to conduct research in neuropsychopharmacology and learn from the very best - Professor Artur Pałasz. I was also a member of the Students Scientific Association in neurology and neurorehabilitation, guided by Agnieszka Gorzkowska, MD, PhD. Following that, I completed my internship at Elena Ziviani’s lab at the University of Padua, where the focus was on molecular aspects of neurodegenerative diseases.

With a background in neurobiology and radiologic technology, I will focus on predicting prognosis in asymptomatic subjects with multiple sclerosis-like brain lesions using cognitive testing and advanced magnetic resonance techniques (a project under the supervision of Maciej Juryńczyk, MD, PhD, Dsc, and Bartosz Kossowski, PhD).

RESEARCH INTERESTS:

neurobiology, neuroanatomy, neuroimaging techniques, neurology, neurorehabilitation

SELECTED PUBLICATIONS:

Pałasz A., Sygidus M., Pinna A., Suszka-Świtek A., Bogus K., Piwowarczyk-Nowak A., Sharma V., Krzystanek M., Menezes-Pazini IC., Filipczyk Ł. (2026). Escitalopram and clonazepam affect gasotransmitter-related enzyme (nNOS, HO-2, CBS) gene expression in the rat brain. Pharmacopsychiatry, doi:10.1055/a-2838-4986.

Pałasz A., Pukowiec M., Bogus K., Suszka-Świtek A., Filipczyk Ł., Mordecka-Chamera K., Worthington J. J., Sygidus M., Wojtas A., Bysiek A., & Gołembiowska K. (2025). Psilocybin and ketamine affect novel neuropeptides gene expression in the rat hypothalamus. Journal of psychopharmacology (Oxford, England), 39(5), 499–508. doi:10.1177/02698811251330783.